T-cell senescence accelerates angiotensin II-induced target organ damage

Abstract Aims Aging is a risk factor for cardiovascular diseases and adaptive immunity has been implicated in angiotensin (Ang) II-induced target organ dysfunction. Herein, we sought to determine the role of T-cell senescence in Ang II-induced target organ impairment and to explore the underlying me...

Full description

Saved in:
Bibliographic Details
Published inCardiovascular research Vol. 117; no. 1; pp. 271 - 283
Main Authors Pan, Xiao-Xi, Wu, Fang, Chen, Xiao-Hui, Chen, Dong-Rui, Chen, Hong-Jin, Kong, Ling-Ran, Ruan, Cheng-Chao, Gao, Ping-Jin
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.01.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Aims Aging is a risk factor for cardiovascular diseases and adaptive immunity has been implicated in angiotensin (Ang) II-induced target organ dysfunction. Herein, we sought to determine the role of T-cell senescence in Ang II-induced target organ impairment and to explore the underlying mechanisms. Methods and results Flow cytometric analysis revealed that T cell derived from aged mice exhibited immunosenescence. Adoptive transfer of aged T cells to immunodeficient RAG1 KO mice accelerates Ang II-induced cardiovascular and renal fibrosis compared with young T-cell transfer. Aged T cells also promote inflammatory factor expression and superoxide production in these target organs. In vivo and in vitro studies revealed that Ang II promotes interferon-gamma (IFN-γ) production in the aged T cells comparing to young T cells. Importantly, transfer of senescent T cell that IFN-γ KO mitigates the impairment. Aged T-cell-conditioned medium stimulates inflammatory factor expression and oxidative stress in Ang II-treated renal epithelial cells compared with young T cells, and these effects of aged T-cell-conditioned medium are blunted after IFN-γ-neutralizing antibody pre-treatment. Conclusion These results provide a significant insight into the contribution of senescent T cells to Ang II-induced cardiovascular dysfunction and provide an attractive possibility that targeting T cell specifically might be a potential strategy to treat elderly hypertensive patients with end-organ dysfunction. Graphical Abstract
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0008-6363
1755-3245
DOI:10.1093/cvr/cvaa032